June 3 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback